Protein FDR Confidence: CombinedAccessionDescriptionExp. q-value: CombinedSum PEP ScoreCoverage [%]# Peptides# PSMs# Unique Peptides# AAsMW [kDa]calc. pIAbundance Ratio: (DKO) / (WT)Abundance Ratio: (SKO) / (WT)Abundance Ratio (log2): (DKO) / (WT)Abundance Ratio (log2): (SKO) / (WT)Abundance Ratio P-Value: (DKO) / (WT)Abundance Ratio P-Value: (SKO) / (WT)Abundance Ratio Adj. P-Value: (DKO) / (WT)Abundance Ratio Adj. P-Value: (SKO) / (WT)Abundances (Grouped): DKOAbundances (Grouped): SKOAbundances (Grouped): WTAbundances (Grouped) CV [%]: DKOAbundances (Grouped) CV [%]: SKOAbundances (Grouped) CV [%]: WTAbundances (Scaled): F1: 127C, Sample, DKO, 1Abundances (Scaled): F1: 128C, Sample, DKO, 2Abundances (Scaled): F1: 129C, Sample, DKO, 3Abundances (Scaled): F1: 130C, Sample, DKO, 4Abundances (Scaled): F1: 129N, Sample, SKO, 1Abundances (Scaled): F1: 130N, Sample, SKO, 2Abundances (Scaled): F1: 131, Sample, SKO, 3Abundances (Scaled): F1: 126, Sample, WT, 1Abundances (Scaled): F1: 127N, Sample, WT, 2Abundances (Scaled): F1: 128N, Sample, WT, 3Abundances (Normalized): F1: 127C, Sample, DKO, 1Abundances (Normalized): F1: 128C, Sample, DKO, 2Abundances (Normalized): F1: 129C, Sample, DKO, 3Abundances (Normalized): F1: 130C, Sample, DKO, 4Abundances (Normalized): F1: 129N, Sample, SKO, 1Abundances (Normalized): F1: 130N, Sample, SKO, 2Abundances (Normalized): F1: 131, Sample, SKO, 3Abundances (Normalized): F1: 126, Sample, WT, 1Abundances (Normalized): F1: 127N, Sample, WT, 2Abundances (Normalized): F1: 128N, Sample, WT, 3Abundance: F1: 127C, Sample, DKO, 1Abundance: F1: 128C, Sample, DKO, 2Abundance: F1: 129C, Sample, DKO, 3Abundance: F1: 130C, Sample, DKO, 4Abundance: F1: 129N, Sample, SKO, 1Abundance: F1: 130N, Sample, SKO, 2Abundance: F1: 131, Sample, SKO, 3Abundance: F1: 126, Sample, WT, 1Abundance: F1: 127N, Sample, WT, 2Abundance: F1: 128N, Sample, WT, 3Abundances Count: F1: 127C, Sample, DKO, 1Abundances Count: F1: 128C, Sample, DKO, 2Abundances Count: F1: 129C, Sample, DKO, 3Abundances Count: F1: 130C, Sample, DKO, 4Abundances Count: F1: 129N, Sample, SKO, 1Abundances Count: F1: 130N, Sample, SKO, 2Abundances Count: F1: 131, Sample, SKO, 3Abundances Count: F1: 126, Sample, WT, 1Abundances Count: F1: 127N, Sample, WT, 2Abundances Count: F1: 128N, Sample, WT, 3Biological ProcessCellular ComponentMolecular FunctionPfam IDsEntrez Gene IDGene SymbolChromosomeReactome PathwaysEnsembl Gene IDKEGG PathwaysWikiPathways# Razor PeptidesModifications
HighP67871Casein kinase II subunit beta OS=Mus musculus OX=10090 GN=Csnk2b PE=1 SV=1031.34946714721524.95.551.3121.1690.390.230.2570078610.3875018270.9512066060.972646624113.1100.786.27.726.6413.56105102.2112.2121.392.9105.696.779.682.8101.7288.7280.9308.3333.3255.3290.3265.8218.7227.4279.4224.8241.8274.6288.3238.4236.5265.8199.9200.4257.75555555555metabolic process;regulation of biological process;response to stimuluschromosome;cytoplasm;membrane;nucleuscatalytic activity;enzyme regulator activity;metal ion binding;protein bindingPf0121413001Csnk2b17WNT mediated activation of DVL; Regulation of TP53 Activity through Phosphorylation; Neutrophil degranulation; Synthesis of PC; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Condensation of Prometaphase Chromosomes; Receptor Mediated Mitophagy; Regulation of PTEN stability and activity; Signal transduction by L1; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not knownENSMUSG00000024387.13Herpes simplex infection; Wnt signaling pathway; Epstein-Barr virus infection; Adherens junction; Ribosome biogenesis in eukaryotes; NF-kappa B signaling pathway; Tight junction; MeaslesTNF-alpha NF-kB Signaling Pathway; Wnt Signaling Pathway NetPath0

[View entry in the full dataset]